Adicet Bio, Inc. (FRA:1IJ)
Germany flag Germany · Delayed Price · Currency is EUR
6.72
-0.30 (-4.27%)
Last updated: Jan 28, 2026, 8:12 AM CET

Adicet Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
---24.999.7317.9
Revenue Growth (YoY)
---156.83%-45.65%1699.30%
Gross Profit
---24.999.7317.9
Selling, General & Admin
23.6128.2926.5326.322.2215.66
Research & Development
97.3699.32106.0471.2547.7533.93
Operating Expenses
120.97127.62132.5897.5469.9749.59
Operating Income
-120.97-127.62-132.58-72.55-60.24-31.69
Interest Expense
-0.01-0-0.03-0.08-0.18-0.13
Interest & Investment Income
6.3210.719.983.760.090.79
Other Non Operating Income (Expenses)
-0.35-0.22-0.57-0.92-0.61-0.95
EBT Excluding Unusual Items
-115.01-117.12-123.2-69.79-60.93-31.99
Merger & Restructuring Charges
------7.1
Impairment of Goodwill
---19.46---
Asset Writedown
-----1.19-2.3
Other Unusual Items
-----1.9
Pretax Income
-115.01-117.12-142.66-69.79-62.12-39.49
Income Tax Expense
-----0.13-2.82
Net Income
-115.01-117.12-142.66-69.79-62-36.68
Net Income to Common
-115.01-117.12-142.66-69.79-62-36.68
Shares Outstanding (Basic)
653320
Shares Outstanding (Diluted)
653320
Shares Change (YoY)
20.10%104.14%4.78%32.72%322.85%242.22%
EPS (Basic)
-20.18-21.33-53.03-27.18-32.05-80.17
EPS (Diluted)
-20.18-21.33-53.03-27.18-32.05-80.17
Free Cash Flow
-100.36-93.5-98.18-61.55-64.1-42.54
Free Cash Flow Per Share
-17.61-17.02-36.50-23.97-33.13-92.99
Gross Margin
---100.00%100.00%100.00%
Operating Margin
----290.32%-619.15%-177.01%
Profit Margin
----279.27%-637.19%-204.87%
Free Cash Flow Margin
----246.29%-658.77%-237.63%
EBITDA
-114.44-121.15-126.48-69.98-58.71-30.47
EBITDA Margin
----280.02%--170.17%
D&A For EBITDA
6.536.476.12.581.541.23
EBIT
-120.97-127.62-132.58-72.55-60.24-31.69
EBIT Margin
----290.32%--177.01%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.